Drug Pricing Realities

Alex sheds light on the challenges of drug pricing, highlighting the skewed incentives in the industry towards blockbuster drugs. He emphasizes the need to unlock potential in developing drugs for smaller markets, calling for a shift in how drugs are tested and validated to make the process more cost-effective.